Health technology assessment (HTA) is a relatively recent innovation that has changed the way decisions are made in healthcare. It is a multidisciplinary process that requires different skill sets and collaboration among various disciplines and agencies. Evidence in the form of systematic reviews or HTAs – and more recently, overviews of systematic reviews – is increasingly being used by decision makers in healthcare globally. Key aims are to reduce duplication of effort and to provide appropriate evidence to assist people to make evidence-informed decisions about health care. Global and regional networks have been established to collaborate on reviews and HTAs, share knowledge, and reduce duplication. However, a very real example of inefficient evidence generation for decision making has been seen with the current COVID-19 pandemic where “eminence-based decisions” (based on the opinions of prominent health professionals) led the way early on. Hopefully, lessons can be learned from this in the future.
Editor-in-Chief
Co-Editors
Managing Editor
Victoria White
Deputy Managing Editor
Alicia Waltman
Associate Editors
Section Editors
Biotechnology
Digital Communication
EMWA News
Getting Your Foot in the Door
Good Writing Practice
Alison McIntosh / Stephen Gilliver
In the Bookstores
Manuscript Writing
Medical Communications/Writing for Patients
Medical Devices
My First Medical Writing
News from the EMA
Out on Our Own
Pharmacovigilance
Regulatory Matters
Regulatory Public Disclosure
Teaching Medical Writing
The Crofter: Sustainable Communications
Veterinary Writing
Editors Emeritus
Lay out Designer
Chris Monk